Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Demeton-S-Methyl SCHEMBL73358 | 1.00 | MAPT (0.52) | MAPTMAPK1ALDH1A1CYP3A4HSD17B10 | |
| Demeton-S-Methyl SCHEMBL5917224 | 0.83 | MEN1 (0.53) | MAPTMAPK1ALDH1A1CYP3A4HSD17B10 | |
| Demeton S SCHEMBL117918 | 0.80 | ALDH1A1 (0.59) | ALDH1A1CYP3A4HSD17B10TDP1MEN1 | |
| Demeton S SCHEMBL6732303 | 0.80 | ALDH1A1 (0.59) | ALDH1A1CYP3A4HSD17B10TDP1MEN1 | |
| SCHEMBL2180857 | 0.78 | ALDH1A1 (0.47) | MAPTMAPK1ALDH1A1CYP3A4HSD17B10 | |
| SCHEMBL11855753 | 0.78 | ALDH1A1 (0.42) | MAPTMAPK1ALDH1A1CYP3A4HSD17B10 | |
| SCHEMBL1359029 | 0.78 | — | — | |
| SCHEMBL117916 | 0.76 | MAPT (0.50) | MAPTMAPK1 | |
| Demeton S SCHEMBL6047148 | 0.74 | MEN1 (0.57) | MAPTMAPK1ALDH1A1CYP3A4HSD17B10 | |
| Demeton S SCHEMBL20544186 | 0.74 | ALDH1A1 (0.52) | ALDH1A1CYP3A4HSD17B10TDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6680065-B2 | FOR TREATMENT OF WOODY PLANTS; EMPLOYED IN HOLLOW PREFORMED IN THE WOODY PLANT | BAYER AKTIENGESELLSCHAFT (DE) | 2004-01-20 | — | — | US | disclosed |
| US-6528079-B2 | For treatment of woody plants; employed in a hollow preformed in the woody plant | BAYER AKTIENGESELLSCHAFT (DE) | 2003-03-04 | — | — | US | disclosed |
| US-20020061323-A1 | SHAPED BODIES WHICH RELEASE AGROCHEMICAL ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2002-05-23 | — | — | US | disclosed |
| US-20010039248-A1 | Shaped bodies which release agrochemical active substances | PODSZUN WOLFGANG (DE) | 2001-11-08 | — | — | US | disclosed |
| EP-0564945-B1 | A method of controlling harmful insects | BAYER AGROCHEM KK (JP) | 2001-01-24 | — | — | EP | disclosed |
| US-6063393-A | RODS OR PINS TO BE PRESSED INTO PLANTS | NIHON BAYER AGROCHEM K.K. (JP) | 2000-05-16 | — | — | US | disclosed |
| EP-0564945-A1 | A method of controlling harmful insects | NIHON BAYER AGROCHEM K.K. (JP) | 1993-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020061323-A1 | SHAPED BODIES WHICH RELEASE AGROCHEMICAL ACTIVE SUBSTANCES | AGL, CHMP4B, GUSB | MAPT 1236/4885MAPK1 4581/4885ALDH1A1 729/4885 |
| US-20010039248-A1 | Shaped bodies which release agrochemical active substances | AGL, CHMP4B, GUSB | MAPT 1193/4885MAPK1 4549/4885ALDH1A1 758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.